You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-CD80 (CD80) Antibodies

Full name:
anti-T-Lymphocyte Activation Antigen CD80 Antibodies (CD80)
On are 0 T-Lymphocyte Activation Antigen CD80 (CD80) Antibodies from different suppliers available. Additionally we are shipping CD80 Proteins (1) and many more products for this protein. A total of 1 CD80 products are currently listed.
B7, B7-1, B7.1, B71, BB1, Cd28l, CD28LG, CD28LG1, LAB7, Ly-53, Ly53, MIC17, TSA1
list all antibodies Gene Name GeneID UniProt
Anti-Mouse CD80 CD80 12519 Q00609
Anti-Human CD80 CD80 941 P33681

Show all synonyms

More Antibodies against CD80 Interaction Partners

Mouse (Murine) T-Lymphocyte Activation Antigen CD80 (CD80) interaction partners

  1. Meningococcal capsular polysaccharide-loaded vaccine nanoparticles induce expression of CD80.

  2. The genetic inactivation of B7.1/B7.2 (show CD86 Antibodies) deteriorates obesity-related liver steatosis and metabolic dysregulation, likely a result of the intrinsic absence of Tregs in these mice, rendering DKO mice a novel murine model of NASH (show SAMSN1 Antibodies).

  3. These results indicate that B7H1 (show CD274 Antibodies)/CD80 interaction augments Tcon cell proliferation, IL-2 (show IL2 Antibodies) production, and expression of PD-1 (show PDCD1 Antibodies), which leads to increased apoptosis

  4. CD28 (show CD28 Antibodies)-CD80 interactions control regulatory T cell motility and immunological synapse formation.

  5. demonstrates that the simultaneous silencing of CD40 (show CD40 Antibodies) and CD80 genes has synergistic effects in preventing allograft rejection, and may therefore have therapeutic potential in clinical transplantation

  6. cardiomyocytes can express CD80; this expression pattern can resist CTL-mediated lysis through CTLA-4 (show CTLA4 Antibodies) pathway

  7. data show an important role of the adaptive immune system, in particular T cell CD80/86 costimulation molecules, in the physiological regulation of bone resorption and preservation of bone mass

  8. CD80 and CD86 (show CD86 Antibodies) costimulatory molecules regulate OT-II CD4 (show CD4 Antibodies)(+) T lymphocyte proliferation and cytokine response in cocultures with antigen-presenting cells derived from pregnant and pseudopregnant mice

  9. The need for additional immune suppression in the intestine reflects commensal microbe-driven T-cell activation through the accessory costimulation molecules ICOSL (show ICOSLG Antibodies) and OX40L (show TNFSF4 Antibodies) in B7 deprived mice.

  10. demonstrate that subcategorizing memory B cells on the basis of their expression of CD80 and PD-L2 (show PDCD1LG2 Antibodies)

Human T-Lymphocyte Activation Antigen CD80 (CD80) interaction partners

  1. CD80-QPAR platform provides a useful predictive model for unknown RA extract's bioactivities using the chemical fingerprint inputs

  2. this study shows that dendritic cells from rheumatoid arthritis patients have low expression levels of CD80

  3. B7-1 is not expressed by podocytes in LN. A renoprotective effect of B7-1 blockade in LN patients cannot be ruled out but, if confirmed, cannot be the result of an effect on podocyte B7-1

  4. analysis of CTLA4 (show CTLA4 Antibodies)-Ig in B7-1-positive diabetic and non-diabetic kidney disease [review]

  5. Genetic interaction of CD80 and ALOX5AP (show ALOX5AP Antibodies) was observed in systemic lupus erythematosus in Asian populations.

  6. Inhibitory Profile of Liver CD68 (show CD68 Antibodies)+ Cells during HCV Infection as Observed by an Increased CD80 and PD-L1 (show CD274 Antibodies) but Not CD86 (show CD86 Antibodies) Expression

  7. Triple costimulation via CD80, 4-1BB (show TNFRSF9 Antibodies), and CD83 (show CD83 Antibodies) ligand elicits the long-term growth of Vgamma9Vdelta2 T cells in low levels of IL-2 (show IL2 Antibodies).

  8. B7-1 is not induced in podocytes from patients with minimal change disease or focal segmental glomerulosclerosis.

  9. In the present study, we investigated the prognostic significance of the expression of three genes in the PD-L1 (show CD274 Antibodies) pathway, including PD-L1 (show CD274 Antibodies), B7.1 and PD-1 (show PDCD1 Antibodies), in three independent bladder cancer datasets in the Gene Expression Omnibus database.

  10. SNP rs1599795 in CD80 3'-UTR (show UTS2R Antibodies), through disrupting the regulatory role of miR (show MLXIP Antibodies)-132-3p, miR (show MLXIP Antibodies)-212-3p, and miR (show MLXIP Antibodies)-361-5p in CD80 expression, contributed to the occurrence of gastric cancer.

CD80 Antigen Profile

Antigen Summary

The protein encoded by this gene is a membrane receptor that is activated by the binding of CD28 or CTLA-4. The activated protein induces T-cell proliferation and cytokine production. This protein can act as a receptor for adenovirus subgroup B and may play a role in lupus neuropathy.

Alternative names and synonyms associated with CD80

  • CD80 antigen (Cd80) antibody
  • CD80 molecule (CD80) antibody
  • B7 antibody
  • B7-1 antibody
  • B7.1 antibody
  • B71 antibody
  • BB1 antibody
  • Cd28l antibody
  • CD28LG antibody
  • CD28LG1 antibody
  • LAB7 antibody
  • Ly-53 antibody
  • Ly53 antibody
  • MIC17 antibody
  • TSA1 antibody

Protein level used designations for CD80

B7 protein , T-lymphocyte activation antigen CD80 , activation B7-1 antigen , B-lymphocyte activation antigen B7 , CD80 antigen (CD28 antigen ligand 1, B7-1 antigen) , CTLA-4 counter-receptor B7.1 , costimulatory factor CD80 , costimulatory molecule variant IgV-CD80

12519 Mus musculus
941 Homo sapiens
100009377 Oryctolagus cuniculus
Did you look for something else?